首页> 外文期刊>The Lancet >Inhaled nitric oxide in neonates with persistent pulmonary hypertension.
【24h】

Inhaled nitric oxide in neonates with persistent pulmonary hypertension.

机译:患有持续性肺动脉高压的新生儿吸入一氧化氮。

获取原文
获取原文并翻译 | 示例
           

摘要

To investigate the oxygenation and haemodynamic dose response to inhaled nitric oxide in neonates with persistent pulmonary hypertension (PPHN), we gave seven neonates nitric oxide and measured directly pulmonary arterial pressure. Inhaled nitric oxide produced peak improvement in oxygenation at 5 parts per million (ppm) whereas peak improvement in the pulmonary-to-systemic arterial pressure ratio did not occur until a nitric oxide dose of 20 ppm, which suggests that an Initial dose of 20 ppm is optimum for the treatment of PPHN.
机译:为了研究持续性肺动脉高压(PPHN)新生儿对吸入一氧化氮的充氧和血流动力学剂量响应,我们给了七名新生儿一氧化氮并直接测量了肺动脉压。吸入一氧化氮的氧化峰值改善为百万分之五(ppm),而直到20 ppm的一氧化氮剂量才出现肺与全身动脉压之比的峰值改善,这表明初始剂量为20 ppm最适合治疗PPHN。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号